Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
US6774226B1 · kind B1 · utility
2Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 30, 1999 |
| Grant date | Aug 10, 2004 |
| Priority date | — |
| Expiry date | Nov 30, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.